MFG
BIIB icon

Magnus Financial Group’s Biogen BIIB Stock Holding History

Magnus Financial Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-694
Closed -$220K – 690
2020
Q1 		$220K Hold
694
– – 0.03% 419
2019
Q4 		$206K Buy
+694
New +$193K 0.03% 491
2019
Q3 		– Sell
-1,315
Closed -$308K – 549
2019
Q2 		$308K Buy
+1,315
New +$304K 0.06% 236

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Magnus Financial Group's BIIB Position: Q2 2020 in Review

Magnus Financial Group sold out of Biogen (BIIB) in Q2 2020, closing a stake of 694 shares — an estimated $220K sold.

Magnus Financial Group first reported a position in BIIB in Q2 2019 and held it in 3 quarters. The position peaked at $308K in Q2 2019. 1,060 funds tracked by Wall St. Rank hold BIIB as of Q2 2020.

  • Magnus Financial Group reported no remaining Biogen position as of Q2 2020 after selling out during the quarter.
  • Magnus Financial Group sold 694 Biogen shares in Q2 2020, an estimated $220K.
  • Magnus Financial Group first reported a position in Biogen in Q2 2019 and held it in 3 quarters.
  • Magnus Financial Group's Biogen position peaked at $308K in Q2 2019.
  • 1,060 funds tracked by Wall St. Rank held Biogen as of Q2 2020.

Based on Magnus Financial Group's 13F filing for Q2 2020, filed 11 Aug 2020.